DEXACIDIN Drug Patent Profile
✉ Email this page to a colleague
When do Dexacidin patents expire, and when can generic versions of Dexacidin launch?
Dexacidin is a drug marketed by Novartis and is included in two NDAs.
The generic ingredient in DEXACIDIN is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXACIDIN?
- What are the global sales for DEXACIDIN?
- What is Average Wholesale Price for DEXACIDIN?
Summary for DEXACIDIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| DailyMed Link: | DEXACIDIN at DailyMed |
US Patents and Regulatory Information for DEXACIDIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | DEXACIDIN | dexamethasone; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 062566-001 | Feb 22, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | DEXACIDIN | dexamethasone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OPHTHALMIC | 062544-001 | Oct 29, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
